Literature DB >> 19867198

A LABILE SERUM FACTOR IN EXPERIMENTAL ENDOTOXIN SHOCK: CROSS-TRANSFUSION STUDIES IN DOGS.

W W Spink1, J Vick.   

Abstract

Peripheral vascular failure caused by endotoxin in the dog has an initial stage of vasoconstriction. Preliminary studies in vitro demonstrated that the constriction was due to the interaction of endotoxin with a heat-labile serum or plasma factor and platelets, resulting in the liberation of histamine. Further studies on the intact dog support and extend this concept. A standardized dose of Escherichia coli endotoxin produced fatal shock in control adult mongrel dogs within 28 hours. The characteristic pattern of changes included progressive hypotension, oliguria and anuria, hemoconcentration, and acidosis. Normal dogs were protected against endotoxin by transfusions of blood in which the essential serum factor was depleted in one of two ways. First, plasma separated from the blood of normal animals was heated at 56 degrees C for 30 minutes, and the infused reconstituted whole blood protected normal dogs. Protection was not afforded by unheated reconstituted blood. Second, blood from immune dogs obtained within 24 hours after a second lethal dose of endotoxin protected recipient dogs. However, protection was not demonstrated with blood collected 72 hours after a second injection of endotoxin. The nature of the serum factor essential for endotoxin activity is not known. It is postulated that an enzyme or enzyme system is involved, and the possible role of complement is discussed.

Entities:  

Year:  1961        PMID: 19867198      PMCID: PMC2180357          DOI: 10.1084/jem.114.4.501

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  Supplementry role of hydralazine in reversal of endotoxin shock with metaraminol and hydrocortisone.

Authors:  J VICK; W W SPINK
Journal:  Proc Soc Exp Biol Med       Date:  1961-02

2.  Increased susceptibility of mice with brucellosis to bacterial endotoxins.

Authors:  R S ABERNATHY; G M BRADLEY; W W SPINK
Journal:  J Immunol       Date:  1958-10       Impact factor: 5.422

3.  A comparison of shock due to endotoxin with anaphylactic shock.

Authors:  M H WEIL; W W SPINK
Journal:  J Lab Clin Med       Date:  1957-10

4.  Homologous and heterologous resistance in mice given bacterial endotoxins.

Authors:  R S ABERNATHY
Journal:  J Immunol       Date:  1957-05       Impact factor: 5.422

5.  Agammaglobulinemia; report of titrations of complement components in a case.

Authors:  J JONSEN; E KASS
Journal:  Acta Pathol Microbiol Scand       Date:  1957

6.  Studies on the circulatory changes in the dog produced by endotoxin from gram-negative microorganisms.

Authors:  L D MACLEAN; W W SPINK; M B VISSCHER; M H WEIL
Journal:  J Clin Invest       Date:  1956-11       Impact factor: 14.808

7.  The influence of Brucella somatic antigen (endotoxin) upon the temperature rhythm of intact mice.

Authors:  F HALBERG; W W SPINK
Journal:  Lab Invest       Date:  1956 May-Jun       Impact factor: 5.662

8.  The susceptibility of mice to bacterial endotoxins.

Authors:  R W SCHAEDLER; R J DUBOS
Journal:  J Exp Med       Date:  1961-03-01       Impact factor: 14.307

  8 in total
  5 in total

1.  Effect of endotoxin on the complement level in sera of precolostral newborn pigs.

Authors:  I Miler; H Tlaskalová; J Kostka; M Jílek
Journal:  Folia Microbiol (Praha)       Date:  1966       Impact factor: 2.099

2.  Interactions of the complement system with the surface and endotoxic lipopolysaccharide of Veillonella alcalescens.

Authors:  H A Bladen; H Gewurz; S E Mergenhagen
Journal:  J Exp Med       Date:  1967-05-01       Impact factor: 14.307

3.  An ultrastructural study of the mechanisms of platelet-endotoxin interaction.

Authors:  A R Spielvogel
Journal:  J Exp Med       Date:  1967-08-01       Impact factor: 14.307

4.  Reduction of serum complement in rabbits after injection of endotoxin.

Authors:  V E GILBERT; A I BRAUDE
Journal:  J Exp Med       Date:  1962-10-01       Impact factor: 14.307

5.  Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.

Authors:  H Gewurz; H S Shin; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.